LifeMD

LifeMD is a diamond in the making

MathieuMRoy

Invested

Community Contributor

Published

10 Apr 25

MathieuMRoy's Fair Value

US$30.30

80.4% undervalued

21 Apr

US$5.95

12.7%

-2.5%

12.7%

-2.5%

Edit anytime before May 14 2:39 AM. Then post Updates to your followers.

Author's Valuation

US$30.3

80.4% undervalued

MathieuMRoy's Fair Value

Narrative

Updates0

MathieuMRoy'sFair Value

US$30.3

80.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

14.57%

Healthtech revenue growth rate

5.06%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.01%

Calculation

US$81.07m

Earnings '30

31.41x

PE Ratio '30

US$2.55b

Market Cap '30

US$2.55b

Market Cap '30

58.06m

No. shares '30

US$43.86

Share Price '30

US$43.86 Share Price '30

Discounted to 2025 @ 7.68% p.a.

US$30.30

Fair Value '25